Therapy News and Research

RSS

Advanced CT scans 100 percent accurate in checking for clogged arteries

In a development that researchers say is likely to quell concerns about the value of costly computed tomography (CT) scans to diagnose coronary artery blockages, an international team led by researchers at Johns Hopkins reports solid evidence that the newer, more powerful 64-CT scans can easily and correctly identify people with major blood vessel disease and is nearly as accurate as invasive coronary angiography.

26 Nov 2008

Study compares strategies for BK virus nephropathy

For kidney transplant recipients with a serious complication called BK virus-associated nephropathy (BKVAN), promptly cutting back on anti-rejection drugs reduces the risk of losing the kidney (graft loss), according to a report in the November Clinical Journal of the American Society of Nephrology (CJASN).

26 Nov 2008

Fruit flies provide new insights into a brain-damaging disease mucolipidosis type IV

Johns Hopkins researchers have used fruit flies to gain new insights into a brain-damaging disorder afflicting children.

26 Nov 2008

Ceregene announces data from phase 2 clinical trial of CERE-120 for Parkinson's

Ceregene, Inc., a biopharmaceutical company, today reported clinical data from a double-blind, controlled Phase 2 trial of CERE-120 in 58 patients with advanced Parkinson's disease.

26 Nov 2008

Better management of arthritis more important than new drugs

Although there has been an increase in the number of new arthritis treatments in recent years, the best results will come from more effective use of the drugs we have.

26 Nov 2008

How microscopy can unlock the key to disease

A leading international scientist will reveal how the latest techniques in microscopy - including time-lapse imaging of living cells - are leading to breakthroughs in understanding genetic and acquired diseases.

26 Nov 2008

Tracking and feedback registry may reduce racial disparities in breast cancer care

Alerting surgeons when their breast cancer patients did not attend a follow-up consultation with a medical oncologist was associated with a reduction in racial disparities in adjuvant therapy, according to a non-randomized study published in the November 25 online issue of the Journal of the National Cancer Institute.

25 Nov 2008

Tiny protein provokes healthy bonding between cells

In human relationships, a certain "spark" often governs whether we prefer one person to another, and critical first impressions can occur within seconds.

25 Nov 2008

Scientists reconstruct bat variant of SARS coronavirus

Researchers at the University of North Carolina at Chapel Hill and Vanderbilt University Medical Center have synthetically reconstructed the bat variant of the SARS coronavirus (CoV) that caused the SARS epidemic of 2003.

25 Nov 2008

Receipt of ventricular assist devices associated with poor outcomes, high costs

Medicare patients who receive ventricular assist devices (a type of heart pump) have high rates of death, illness, prolonged hospital stays, with resulting high costs of care, according to a study in the November 26 issue of JAMA.

25 Nov 2008

Follow up results from first case of pulmonary hypertension treated with stem cells

Dr. Leonel Fernandez Liriano, Professor of Medicine at Pontifical Catholic University School of Medicine (PCUSM), announced nine month follow up results for the first patient treated with engineered stem cells in a clinical study of primary pulmonary hypertension.

25 Nov 2008

Selzentry (maraviroc) becomes fully approved HIV antiretrovial

The U.S. Food and Drug Administration (FDA) has granted Selzentry (maraviroc) full (traditional) approval for use in treatment-experienced adults with CCR5-tropic HIV-1 in combination with other antiretrovirals.

25 Nov 2008

Mammogram most effective 12 months after radiation

Breast cancer patients who receive breast-conserving therapy and radiation do not need a follow-up mammogram until 12 months after radiation, despite current guidelines that recommend follow-up mammograms at between six and 12 months after radiation, according to a November 15 study in the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Therapeutic Radiology and Oncology.

25 Nov 2008

Researchers urge physicians to test for fragile X gene mutations in patients of all ages

Writing in this week's Journal of the American Medical Association , UC Davis M.I.N.D. Institute researchers urge physicians to test for mutations of the fragile X gene in patients of all ages.

25 Nov 2008

Call for greater caution in prescribing inhaled corticosteroids to COPD sufferers

Lung disease experts at Johns Hopkins are calling for physicians to show much greater caution in prescribing inhaled corticosteroid drugs for people with chronic obstructive pulmonary disease after finding evidence that the widely used anti-inflammatory medications increase the risk of pneumonia by a full third.

25 Nov 2008

Therapy News and Research

Advanced CT scans 100 percent accurate in checking for clogged arteries

Study compares strategies for BK virus nephropathy

Fruit flies provide new insights into a brain-damaging disease mucolipidosis type IV

Ceregene announces data from phase 2 clinical trial of CERE-120 for Parkinson's

Better management of arthritis more important than new drugs

How microscopy can unlock the key to disease

Tracking and feedback registry may reduce racial disparities in breast cancer care

Tiny protein provokes healthy bonding between cells

Scientists reconstruct bat variant of SARS coronavirus

Receipt of ventricular assist devices associated with poor outcomes, high costs

Follow up results from first case of pulmonary hypertension treated with stem cells

Selzentry (maraviroc) becomes fully approved HIV antiretrovial

Mammogram most effective 12 months after radiation

Researchers urge physicians to test for fragile X gene mutations in patients of all ages

Call for greater caution in prescribing inhaled corticosteroids to COPD sufferers

Hormone therapy could be dangerous for women pre-existing heart disease risk factors

CardioVascular BioTherapeutics doses first patient in trial for severe coronary heart disease

Researchers repair injured heart muscle with novel stem cells

Scientists develop peptide that converts Bcl-2 protein from a cancer cell's friend to a foe

Scientists develop 'barcode chip' to revolutionize diagnostic medical testing

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News